2019
DOI: 10.1177/0003319719851698
|View full text |Cite
|
Sign up to set email alerts
|

CHA2DS2VASc Score and Coronary No-Reflow Phenomenon

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
3
0
2

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 6 publications
0
3
0
2
Order By: Relevance
“…Esses mecanismos são relatados como disfunção microvascular pré-existente, espasmo arteriolar microvascular, tromboembolização distal devido à alta atividade plaquetária e carga trombótica, lesão de reperfusão isquêmica, edema das células do miocárdio comprimindo os vasos microvasculares. 1 - 3 Portanto, a patogênese e mecanismos do CNP permanecem controversos.…”
Section: Discussionunclassified
See 3 more Smart Citations
“…Esses mecanismos são relatados como disfunção microvascular pré-existente, espasmo arteriolar microvascular, tromboembolização distal devido à alta atividade plaquetária e carga trombótica, lesão de reperfusão isquêmica, edema das células do miocárdio comprimindo os vasos microvasculares. 1 - 3 Portanto, a patogênese e mecanismos do CNP permanecem controversos.…”
Section: Discussionunclassified
“…These reported mechanisms are such as pre-existing microvascular dysfunction, microvascular arteriolar spasm, distal thrombo-embolization due to high platelet activity and thrombus burden, ischemic-reperfusion injury, and swelling of myocardial cells compressing microvascular vessels. 1 - 3 Therefore, the pathogenesis and mechanisms of CNP remain controversial.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…1,3 Th e pathophysiologies of slow-fl ow and no-refl ow phenomenons are complex and multifactorial, such as, infl ammation, atherothrombotic microembolization, activation of neutrophils and platelets, which cause releasing of oxygen-free radicals, proteolytic enzymes, and proinfl ammatory mediators that can cause tissue and endothelial damage. 4 Also, coronary spasm and reperfusion injury, myocardial dysfunction, valvular heart disease and certain connective tissue disorders involving coronary microvasculature, as well as genetic predisposition may play a part in the pathophysiology of slow-fl ow and no-refl ow phenomenons. 5,6 CSFP also results from inadvertent air-embolism during angioplasty or may be due to an overlooked ostial lesion.…”
Section: Introductionmentioning
confidence: 99%